These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 35356444)
21. Neurocognitive and executive functioning in adult survivors of congenital heart disease. Klouda L; Franklin WJ; Saraf A; Parekh DR; Schwartz DD Congenit Heart Dis; 2017 Jan; 12(1):91-98. PubMed ID: 27650247 [TBL] [Abstract][Full Text] [Related]
22. Fontan circulation has improved life expectancy for infants born with complex heart disease over the last 50 years but has also resulted in significant morbidity. Hedlund E; Lundell B Acta Paediatr; 2022 Jan; 111(1):11-16. PubMed ID: 34235784 [TBL] [Abstract][Full Text] [Related]
23. Executive Function in Children and Adolescents with Critical Cyanotic Congenital Heart Disease. Cassidy AR; White MT; DeMaso DR; Newburger JW; Bellinger DC J Int Neuropsychol Soc; 2015 Jan; 21(1):34-49. PubMed ID: 25487044 [TBL] [Abstract][Full Text] [Related]
25. Quality of Life and Other Patient-Reported Outcomes Across the Life Span Among People With Fontan Palliation. Kasparian NA; Kovacs AH Can J Cardiol; 2022 Jul; 38(7):963-976. PubMed ID: 35525399 [TBL] [Abstract][Full Text] [Related]
26. A Path FORWARD: Development of a Comprehensive Multidisciplinary Clinic to Create Health and Wellness for the Child and Adolescent with a Fontan Circulation. Rychik J; Goldberg DJ; Rand E; Mancilla EE; Heimall J; Seivert N; Campbell D; O'Malley S; Dodds KM Pediatr Cardiol; 2022 Aug; 43(6):1175-1192. PubMed ID: 35604474 [TBL] [Abstract][Full Text] [Related]
27. Pediatric Patients Undergoing a Fontan Operation or with a High RACHS-1 Score Require Monitoring for Chronic Kidney Disease in Early Childhood. Nakae K; Ueno K; Shiokawa N; Takahashi Y; Kawamura J; Hazeki D; Imoto Y; Kawano Y Pediatr Cardiol; 2022 Jun; 43(5):1020-1028. PubMed ID: 35028678 [TBL] [Abstract][Full Text] [Related]
28. Regional variation in quality of life in patients with a Fontan circulation: A multinational perspective. Fogleman ND; Apers S; Moons P; Morrison S; Wittekind SG; Tomlin M; Gosney K; Sluman MA; Johansson B; Enomoto J; Dellborg M; Lu CW; Subramanyan R; Luyckx K; Budts W; Jackson J; Kovacs A; Soufi A; Eriksen K; Thomet C; Berghammer M; Callus E; Fernandes SM; Caruana M; Cook SC; Mackie AS; White KS; Khairy P; Kutty S; Veldtman G; Am Heart J; 2017 Nov; 193():55-62. PubMed ID: 29129255 [TBL] [Abstract][Full Text] [Related]
29. Neuroplacentology in congenital heart disease: placental connections to neurodevelopmental outcomes. Leon RL; Mir IN; Herrera CL; Sharma K; Spong CY; Twickler DM; Chalak LF Pediatr Res; 2022 Mar; 91(4):787-794. PubMed ID: 33864014 [TBL] [Abstract][Full Text] [Related]
30. Long-Term Neurodevelopmental Outcomes in Children and Adolescents With Congenital Heart Disease. Jerrell JM; Shuler CO; Tripathi A; Black GB; Park YM Prim Care Companion CNS Disord; 2015; 17(5):. PubMed ID: 26835177 [TBL] [Abstract][Full Text] [Related]
31. Transplantation for Congenital Heart Disease: Focus on the Impact of Functionally Univentricular Versus Biventricular Circulation. Riggs KW; Broderick JT; Price N; Chin C; Zafar F; Morales DLS World J Pediatr Congenit Heart Surg; 2021 May; 12(3):352-359. PubMed ID: 33942695 [TBL] [Abstract][Full Text] [Related]
33. Committed to Life: Adolescents' and Young Adults' Experiences of Living with Fontan Circulation. Berghammer MC; Brink E; Rydberg AM; Dellborg M; Ekman I Congenit Heart Dis; 2015; 10(5):403-12. PubMed ID: 25564938 [TBL] [Abstract][Full Text] [Related]
34. Clinical features of very-low-birthweight infants with congenital heart disease. Tomotaki H; Toyoshima K; Tomotaki S; Shimokaze T; Kim KS; Kawataki M Pediatr Int; 2021 Jul; 63(7):806-812. PubMed ID: 33247990 [TBL] [Abstract][Full Text] [Related]
35. Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association. Marino BS; Lipkin PH; Newburger JW; Peacock G; Gerdes M; Gaynor JW; Mussatto KA; Uzark K; Goldberg CS; Johnson WH; Li J; Smith SE; Bellinger DC; Mahle WT; Circulation; 2012 Aug; 126(9):1143-72. PubMed ID: 22851541 [TBL] [Abstract][Full Text] [Related]
36. Exercise Intolerance, Benefits, and Prescription for People Living With a Fontan Circulation: The Fontan Fitness Intervention Trial (F-FIT)-Rationale and Design. Tran DL; Gibson H; Maiorana AJ; Verrall CE; Baker DW; Clode M; Lubans DR; Zannino D; Bullock A; Ferrie S; Briody J; Simm P; Wijesekera V; D'Almeida M; Gosbell SE; Davis GM; Weintraub R; Keech AC; Puranik R; Ugander M; Justo R; Zentner D; Majumdar A; Grigg L; Coombes JS; d'Udekem Y; Morris NR; Ayer J; Celermajer DS; Cordina R Front Pediatr; 2021; 9():799125. PubMed ID: 35071139 [No Abstract] [Full Text] [Related]
37. A cluster randomized trial of a transition intervention for adolescents with congenital heart disease: rationale and design of the CHAPTER 2 study. Mackie AS; Rempel GR; Kovacs AH; Kaufman M; Rankin KN; Jelen A; Manlhiot C; Anthony SJ; Magill-Evans J; Nicholas D; Sananes R; Oechslin E; Dragieva D; Mustafa S; Williams E; Schuh M; McCrindle BW BMC Cardiovasc Disord; 2016 Jun; 16():127. PubMed ID: 27266868 [TBL] [Abstract][Full Text] [Related]
40. State of the art of the Fontan strategy for treatment of univentricular heart disease. van der Ven JPG; van den Bosch E; Bogers AJCC; Helbing WA F1000Res; 2018; 7():. PubMed ID: 30002816 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]